A detailed history of Cedar Mountain Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 863 shares of PFE stock, worth $23,059. This represents 0.01% of its overall portfolio holdings.

Number of Shares
863
Previous 853 1.17%
Holding current value
$23,059
Previous $23,000 4.35%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $277 - $313
10 Added 1.17%
863 $24,000
Q2 2024

Jul 11, 2024

BUY
$25.26 - $29.6 $277 - $325
11 Added 1.31%
853 $23,000
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $284 - $327
11 Added 1.32%
842 $23,000
Q4 2023

Jan 16, 2024

BUY
$26.13 - $33.94 $235 - $305
9 Added 1.09%
831 $23,000
Q3 2023

Oct 23, 2023

BUY
$32.09 - $37.51 $256 - $300
8 Added 0.98%
822 $27,000
Q2 2023

Jul 19, 2023

BUY
$36.12 - $41.79 $252 - $292
7 Added 0.87%
814 $29,000
Q1 2023

Apr 11, 2023

BUY
$39.39 - $51.28 $236 - $307
6 Added 0.75%
807 $32,000
Q4 2022

Jan 11, 2023

BUY
$41.75 - $54.5 $208 - $272
5 Added 0.63%
801 $41,000
Q3 2022

Oct 11, 2022

BUY
$43.76 - $53.42 $262 - $320
6 Added 0.76%
796 $35,000
Q2 2022

Jul 14, 2022

BUY
$46.53 - $55.17 $232 - $275
5 Added 0.64%
790 $41,000
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $228 - $283
5 Added 0.64%
785 $41,000
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $206 - $306
5 Added 0.65%
780 $46,000
Q3 2021

Oct 15, 2021

SELL
$39.25 - $50.42 $2,629 - $3,378
-67 Reduced 7.96%
775 $33,000
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $10,041 - $12,768
300 Added 55.35%
842 $31,000
Q4 2019

Jan 30, 2020

BUY
$32.92 - $37.36 $17,842 - $20,249
542 New
542 $21,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.